EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 821-828

  Block, Robert C ^a   Harris, William S ^b,c   Reid, Kimberly J ^b   Sands, Scott A ^b   Spertus, John A ^b,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Case control studies; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID; OMEGA 3 FATTY ACID; STATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO;

EID: 40949102602     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.07.042     Document Type: Article

References (39)

1. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
2. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
3. Ascherio A., Rimm E.B., Stampfer M.J., Giovannucci E.L., and Willett W.C. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 332 (1995) 977-982
4. Morris M.C., Manson J.E., Rosner B., et al. Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. Am J Epidemiol 142 (1995) 166-175
5. Hu F.B., Bronner L., Willett W.C., et al. Fish and omega-3 fatty acid intake and risk risk of coronary heart disease in women. JAMA 287 (2002) 1815-1821
6. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2 (1989) 757-761
7. Marchioli R., Federica B., Bomba E., and on behalf of the GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
8. Rissanen T., Voutilainen S., Nyyssonen K., Lakka T.A., and Salonen J.T. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 102 (2000) 2677-2679
9. Erkkila A.T., Lehto S., Pyorala K., and Uusitupa M.I. n-3 Fatty acids and 5-year risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 78 (2003) 65-71
10. Hallgren C.G., Hallmans G., Jansson J.H., et al. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 86 (2001) 397-404
11. Guallar E., Aro A., Jiminez F.J., et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arteriosclerosis Thromb Vasc Biol 19 (1999) 1111-1118
12. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
13. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
14. Lanfear D.E., Jones P.G., Marsh S., et al. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 294 (2005) 1526-1533
15. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
16. Harris W.S., and von Schacky C. The Omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
17. Studer M., Briel M., Leimenstoll B., Glass T.R., and Bucher H.C. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 165 (2005) 725-730
18. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110 (2004) 1645-1649
19. Gaziano J.M., Hennekens C.H., Satterfield S., et al. Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction. Vasc Med 4 (1999) 227-231
20. Lemaitre R.N., King I.B., Mozaffarian D., et al. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am J Clin Nutr 77 (2003) 319-325
21. Lemaitre R.N., King I.B., Raghunathan T.E., et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105 (2002) 697-701
22. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 (2002) 1113-1118
23. Luostarinen R., Boberg M., and Saldeen T. Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis 99 (1993) 187-193
24. Lemaitre R.N., King I.B., Mozaffarian D., et al. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 77 (2003) 319-325
25. Kirkeby K., Ingvaldsen P., and Bjerkedal I. Fatty acid composition of serum lipids in men with myocardial infarction. Acta Med Scand 192 (1972) 513-519
26. Lea E.J., Jones S.P., and Hamilton D.V. The fatty acids of erythrocytes of myocardial infarction patients. Atherosclerosis 41 (1982) 363-369
27. Skuladottir G., Hardarson T., Sigfusson N., Oddsson G., and Gudbjarnason S. Arachidonic acid levels in serum phospholipids of patients with angina pectoris or fatal myocardial infarction. Acta Med Scand 218 (1985) 55-58
28. Wood D.A., Riemersma R.A., Butler S., et al. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1 (1987) 177-183
29. Miettinen T.A., Naukkarinen V., Huttenen J.K., Mattila S., and Kumlin T. Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J 285 (1982) 993-996
30. Oda E., Hatada K., Katoh K., et al. A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction. Int Heart J 46 (2005) 583-591
31. Simon J.A., Hodgkins M.L., Browner W.S., et al. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 142 (1995) 469-476
32. Sands S.A., Reid K.J., Windsor S.L., and Harris W.S. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 40 (2005) 343-347
33. Wang L., Folsom A.R., and Eckfeldt J.H. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the atherosclerosis risk in communities (ARIC) Study. Nutr Metab Cardiovasc Dis 13 (2003) 256-266
34. Jurand J., and Oliver M.F. Effects of acute myocardial infarction and of noradrenaline infusion on fatty acid composition of serum lipids. Atherosclerosis 11 (1970) 157-170
35. Kark J.D., Manor O., Goldman S., and Berry E.M. Stability of red blood cell membrane fatty acid composition after acute myocardial infarction. J Clin Epidemiol 48 (1995) 889-895
36. Maidment C.G., Jones S.P., and Lea E.J. Changes in platelet membrane fatty acids after myocardial infarction. Atherosclerosis 74 (1988) 9-14
37. Harris W.S., Poston W.C., and Haddock C.K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (2007) 1-10
38. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91 (2006) 439-446
39. Niu K., Hozawa A., Kuriyama S., et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 84 (2006) 223-229